Regulatory: The Emerging C-Suite Leader
Candid conversations that go beyond the “what” of regulation into the “how” and “why” of leadership: decision-making, influence, and navigating uncertainty.
Podcasts
10-06-2026
Why CMC Needs a Seat at the Executive Table
Edward Kaye, CEO of Aurora Therapeutics, discusses why CMC is often one of the most consequential and underestimated areas of drug development.
30-04-2026
Regulatory Strategy for Accelerated Programs
Murray Abramson, Chief Development Officer at Ascidian, explores what it takes to accelerate drug development in complex settings, particularly in diseases with limited patient populations.
27-03-2026
Building the Investor Narrative
Rami Rahal, an investor at a leading biotech investment firm with a background spanning genetic research, brings a practical lens on what makes a biotech company fundable.
20-02-2026
From Preclinical to Proof of Concept: FIH Challenges
Gilmore O’Neill, neurologist and CEO of Editas, unpacks what strong regulatory leadership looks like when a biotech is racing toward first-in-human (FIH) and proof of concept.
LET'S TALK
You don't have to go it alone!
Our experienced team has been there before, and we're ready to guide you through the unknown.Share your challenges with us, and together, we'll create a plan to efficiently reach your milestones and turn your vision into reality.
Building Better Biotechs
